Stereotactic ablative radiotherapy and durvalumab: The backbone of unresectable locally advanced non-small cell lung cancer patients unfit to concurrent chemo-radiotherapy - Rib of START-NEW-ERA trial

被引：0
|
作者：
Arcidiacono, F. [1 ]
Trippa, F. [1 ]
Maranzano, E. [1 ]
Italiani, M. [1 ]
Casale, M. [1 ]
Anselmo, P. [1 ]
机构：
[1] S Maria Hosp, Oncol, Terni, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127P
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [31] Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
    Landman, Yosef
    Jacobi, Oded
    Kurman, Noga
    Yariv, Orly
    Peretz, Idit
    Rotem, Ofer
    Dudnik, Elizabeth
    Zer, Alona
    Allen, Aaron M.
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [32] Durvalumab after Concurrent cChemotherapy and High-Dose Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Landman, Y.
    Kurman, N.
    Jacobi, O.
    Yariv, O.
    Peretz, I.
    Rotem, O.
    Dudnik, E.
    Zer, A.
    Allen, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S368 - S368
  • [33] Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis
    Viani, Gustavo A.
    Gouveia, Andre G.
    Louie, Alexander, V
    Arcidiacono, Fabio
    Simone II, Charles B.
    Tsakiridis, Theodoros
    Hamamura, Ana Carolina
    Anselmo, Paola
    Moraes, Fabio Y.
    RADIOTHERAPY AND ONCOLOGY, 2024, 201
  • [34] Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review
    Liang, Hui-Ying
    Zhou, Hao
    Li, Xue-Lian
    Yin, Zhi-Hua
    Guan, Peng
    Zhou, Bao-Sen
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) : 718 - 728
  • [35] Prognostic Value of Early Tumor Regression during Chemo-Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Lin, Angela
    Bezjak, Andrea
    Lim, Gerald
    Le, Lisa
    Higgins, Jane
    Bissonnette, Jean-Pierre
    Sun, Alexander
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S875 - S876
  • [36] Alteration in tumor immune microenvironment after chemo-radiotherapy for locally advanced non-small cell lung cancer.
    Yoneda, Kazue
    Kuwata, Taiji
    Mori, Masataka
    Kanayama, Masatoshi
    Kuroda, Koji
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy
    Sanz Rubiales, Alvaro
    del Valle River, Maria Luisa
    Fiorini Talavera, Aldo Bruno
    Fernandez Gonzalez, Maria
    LUNG CANCER, 2015, 89 (01) : 84 - 85
  • [38] Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer
    Yavas, G.
    Yavas, C.
    Akyurek, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 801 - 802
  • [39] PHASE II TRIAL: CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY WITH NITROGLYCERIN IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    De La Mata, Dolores
    Blake-Cerda, Monika
    Zamora, Jesus
    Pena, Omar
    Flores-Estrada, Diana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S133 - S134
  • [40] Phase II trial: Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer patients
    De la Mata, Dolores
    Blake, Monika
    Zamora Moreno, Jesus
    Pena, Omar
    Flores-Estrada, Diana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345